Several abstracts that were supported by CARRA-Arthritis Foundation grants or other CARRA infrastructure were presented at ACR. We've pulled together a listing. Click below to find out more.
Thank you to everyone who joined us at the CARRA activities held during the 2018 ACR/ARHP Annual Conference. We had a great turnout at the CARRA meeting, CARRA/Arthritis Foundation Co-hosted Reception, and CARRA Fellow/Early Investigator Reception. Additionally, several CARRA-related projects were presented in sessions and as posters. Read on for more information and to see some photos of the action.
Approximately 300 people attended CARRA’s Annual Meeting at ACR. CARRA President Rob Fuhlbrigge updated attendees on CARRA, the CARRA Registry and other CARRA research activities. CARRA Past-President Yuki Kimura then introduced the second portion of the agenda, which included a panel discussion about two important meetings that were planned in collaboration with the Arthritis Foundation and held earlier this year. Panelists included the Arthritis Foundation’s Guy Eakin and Suzanne Schrandt, CARRA’s Vincent Del Gaizo, and JIA parent Corrine Pinter. The first meeting, “New Approaches to Evaluate the Efficacy and Safety of Therapeutics for JIA, A CARRA-Sponsored discussion”, was held on April 22 in Denver and included patients, parents, clinicians, research investigators, clinical trial experts, as well as representatives from industry, the FDA and EMA, and the Arthritis Foundation. The meeting addressed the critical issues we face today in clinical trial design that will impede timely authorization of new medicines for JIA. The second meeting was an externally-led FDA Patient Focused Drug Development (PFDD) meeting in Washington DC on August 2n. The goal of the meeting was to inform the FDA and industry about patient/caregiver viewpoints about the disease and treatment burdens of JIA, including the urgent need for new and better treatments. The panelists provided their impressions of the value of these two meetings from the perspectives of CARRA, the Arthritis Foundation and the patient/ parent participants. Publications resulting from both meetings will be available soon.
Attendees gathered after the CARRA Meeting to network and visit with colleagues, friends, and parent/patient attendees, over great food and drinks. CARRA and the Arthritis Foundation each staffed displays with more information about each organization.
14 CARRA related projects were presented during the meeting. Of those, 6 were supported by CARRA-Arthritis Foundation grants. For more information about these projects, please visit the CARRA website here.
This reception offered a great opportunity for CARRA Fellows and Early Investigators to network and to introduce other ACR attendees to CARRA.
We would like to extend a special thank you to the Arthritis Foundation for supporting CARRA’s activities at ACR and throughout the year.
Contact the CARRA Business Office with any questions, [email protected] or 414-918-9822.